I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Ettrich, T. J.
61
results:
english X
Search for persons
X
Format
Online (61)
Mediatypes
Articles (Online) (29)
OpenAccess-fulltext (32)
Sorted by: Relevance
Sorted by: Year
?
1
Corrigendum to "Prognostic and predictive value of CA 19-9 ..:
Hartlapp, I.
;
Valta-Seufzer, D.
;
Siveke, J.T.
...
ESMO Open. 9 (2024) 5 - p. 103463 , 2024
Link:
https://doi.org/10.1016/..
?
2
191P Evaluating sorafenib as second-line treatment for adva..:
Möhring, C.
;
Berger, M.
;
Sadeghlar, F.
...
Annals of Oncology. 35 (2024) - p. S86 , 2024
Link:
https://doi.org/10.1016/..
?
3
386P Exploratory biomarker analysis based on the PREDICT tr..:
Lahusen, A.
;
Lutz, M.P.
;
Karthaus, M.
...
Annals of Oncology. 35 (2024) - p. S155 , 2024
Link:
https://doi.org/10.1016/..
?
4
424P Pembrolizumab and olaparib in advanced HER2-negative e..:
Haag, G.M.
;
Goetze, T.O.
;
Thuss-Patience, P.C.
...
Annals of Oncology. 35 (2024) - p. S172-S173 , 2024
Link:
https://doi.org/10.1016/..
?
5
S-1 maintenance therapy in Caucasian patients with metastat..:
Stocker, G.
;
Lorenzen, S.
;
Ettrich, T.
...
ESMO Open. 8 (2023) 3 - p. 101572 , 2023
Link:
https://doi.org/10.1016/..
?
6
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a pr..:
Sommerhäuser, G.
;
Kurreck, A.
;
Stintzing, S.
...
BMC Cancer. 22 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
7
Prognostic and predictive value of CA 19-9 in locally advan..:
Hartlapp, I.
;
Valta-Seufzer, D.
;
Siveke, J.T.
...
ESMO Open. 7 (2022) 4 - p. 100552 , 2022
Link:
https://doi.org/10.1016/..
?
8
Efficacy, safety and quality-of-life data from patients wit..:
Weiss, L.
;
Karthaus, M.
;
Riera-Knorrenschild, J.
...
ESMO Open. 7 (2022) 1 - p. 100391 , 2022
Link:
https://doi.org/10.1016/..
?
9
Prognosis and tumor biology of pancreatic cancer patients w..:
Kruger, S.F.
;
Lohneis, A.
;
Abendroth, A.
...
ESMO Open. 7 (2022) 1 - p. 100388 , 2022
Link:
https://doi.org/10.1016/..
?
10
Dynamics in treatment response and disease progression of m..:
Kurreck, A.
;
Geissler, M.
;
Martens, U. M.
...
Journal of Cancer Research and Clinical Oncology. 146 (2020) 10 - p. 2681-2691 , 2020
Link:
https://doi.org/10.1007/..
?
11
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcit..:
Perkhofer, L.
;
Berger, A. W.
;
Beutel, A. K.
...
BMC Cancer. 19 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
?
12
Genotyping of circulating tumor DNA in cholangiocarcinoma r..:
Ettrich, T. J.
;
Schwerdel, D.
;
Dolnik, A.
...
Scientific Reports. 9 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1038/..
?
13
A multicentre, phase IIa study of zolbetuximab as a single ..:
Türeci, O.
;
Sahin, U.
;
Schulze-Bergkamen, H.
...
Annals of Oncology. 30 (2019) 9 - p. 1487-1495 , 2019
Link:
https://doi.org/10.1093/..
?
14
Advantages of a multi-state approach in surgical research: ..:
Manzini, G.
;
Ettrich, T. J.
;
Kremer, M.
...
BMC Medical Research Methodology. 18 (2018) 1 - p. , 2018
Link:
https://doi.org/10.1186/..
?
15
Efficacy of gemcitabine plus erlotinib in rash-positive pat..:
Haas, M.
;
Siveke, J.T.
;
Schenk, M.
...
European Journal of Cancer. 94 (2018) - p. 95-103 , 2018
Link:
https://doi.org/10.1016/..
1-15